Table 2.
Characteristics of Fistula Cohort by Low Muscle Quality
| Total Cohort (n=100) | LMQ Cohort (n=25) | LMQ Cohort (n=75) | p-value | |
|---|---|---|---|---|
| Patient Characteristics | ||||
| Age (years) | 56.5 (14.4) | 58.6 (11.8) | 55.8 (15.1) | 0.40 |
| Sex | 54.0% Female | 56.0% Female | 53.3% Female | 0.86 |
| BMI | 27.8 (9.9) | 33.2 (10.7) | 26.0 (8.8) | 0.002* |
| #Comorbidities | 5.0 (3.0) | 5.1 (2.2) | 5.0 (3.2) | 0.83 |
| #Medications | 9.5 (5.5) | 10.4 (5.0) | 9.1 (5.6) | 0.33 |
| MFI | 1.1 (1.3) | 1.8 (1.6) | 1.0 (1.1) | 0.01* |
| IBD | 14 (14.0%) | 3 (12.0%) | 11 (14.7%) | 0.52 |
| Cancer History | 12 (12.0%) | 3 (12.0%) | 9 (12.0%) | 0.62 |
| Pre-op TPN | 63 (63.0%) | 13 (52.0%) | 50 (66.7%) | 0.27 |
| Pre-op Albumin | 2.8 (0.7) | 2.6 (0.7) | 2.9 (0.6) | 0.11 |
| Pre-op Pre-Albumin | 15.3 (7.7) | 14.0 (8.0) | 15.9 (7.6) | 0.34 |
| #Months from Fistula | 7.3 (11.7) | 4.3 (3.6) | 8.0 (12.9) | 0.25 |
| #Months from CT Scan | 1.1 (0.9) | 0.9 (0.9) | 1.2 (0.9) | 0.10 |
| ECF Characteristics | ||||
| EAF vs ECF | 21 (21%) EAF | 6 (24%) EAF | 15 (20%) EAF | 0.67 |
| #Tracts | 1.4 (0.7) | 1.6 (1.1) | 1.3 (0.6) | 0.04* |
| Location | 92 (92%) SB | 21 (84%) SB | 71 (95%) SB | 0.09 |
LMQ; low muscle quality, BMI; body mass index, MFI; modified frailty index, IBD; inflammatory bowel disease, TPN; total parenteral nutrition, EAF; entero-atmospheric fistula, ECF; enterocutaneous fistula, SB; small bowel, values are means or total number in group, values in parenthesis are standard deviation, or percentage of total group,
*
marks significance α = 0.05 level